Medical devices, healthcare technology and the business of care
510(k) clearance · K260261

Gravity Blood Sets with 200µm Filter

B. BRAUN MEDICAL INC. · Decision date Oct 22, 2026

MEDTECHLEDGER EXPLANATIONK260261

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision on 2026-10-22 for K260261, a traditional 510(k) submitted by B.Braun Medical, Inc. of Bethlehem, Pennsylvania, and received on 01/28/2026. The device is listed as Gravity Blood Sets with 200µm Filter, classified under regulation 880.5440 as an intravascular administration set with product code FPA in the General Hospital specialty. SESE denotes clearance to market, not premarket approval of the device.

The record identifies the applicant contact as Stacia Preston and notes the review was not conducted by a third party, was not a combination product, and carried no authorized predetermined change control plan. The available material does not include the summary's substantive content, so the specific component changes, predicate device, and any performance data supporting equivalence remain unknown. No clinical, safety, or labeling conclusions are drawn here.

Regulatory pathway
510(k) premarket notification
Clinical specialty
General Hospital
Decision date
Oct 22, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K260261
Regulatory pathway
510(k) premarket notification
Product code
FPA
Decision code
SESE
Decision date
Oct 22, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Set, Administration, Intravascular.

Product code
FPA
FDA device class
2

FDA decision timeline

  1. K260261 received

    Application receipt date recorded by FDA.

  2. K260261 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code FPA

Product / regulatory recordCompanyPathwayDecision dateSource
Ecomed Solutions, LLC510(k) clearanceSep 11, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

B. BRAUN MEDICAL INC.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Bethlehem, PA

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records